Active
TERM 1
January 27, 2025 · 582 days ago
🏥 Healthcare
On January 27, 2025, President Trump signed Executive Order 14184 directing the reinstatement of service members who were discharged under the military's COVID-19 vaccination mandate. The order requires the Department of Defense to reinstate affected service members and may provide back pay and benefits restoration. The confirmed direct impact includes restoring military status and pay for service members previously separated from the armed forces.
Active
TERM 2
January 2025 · 585 days ago
🏥 Healthcare
President Trump signed an executive order instructing the CDC to reduce the number of recommended childhood vaccines by approximately 50%. The order uses vague language referring to a health department assessment as a guide for federal immunization policy. The action directly threatens childhood disease prevention and herd immunity protections across the United States.
Active
TERM 1
January 24, 2025 · 585 days ago
🏥 Healthcare
On January 24, 2025, President Trump signed Executive Order 14182 directing federal agencies to enforce the Hyde Amendment, which prohibits federal funds from being used to pay for abortion services except in cases of rape, incest, or danger to the mother's life. The order requires agencies to withhold federal funding from any organization that provides, refers for, or covers abortion services. The confirmed direct impact includes potential loss of federal funding for Planned Parenthood and other healthcare providers that offer abortion services alongside other medical care.
Active
TERM 2
January 2025 · 586 days ago
🏥 Healthcare
The Trump administration halted direct federal funding to community-based organizations conducting HIV prevention work, citing efforts to eliminate DEI-focused initiatives. The freeze eliminates resources for LGBTQ-serving health organizations despite the White House's stated goal of ending the HIV epidemic by 2030. The action directly contradicts stated public health objectives and undermines decades of community-based prevention infrastructure.
Active
TERM 2
January 23 2025 · 586 days ago
🏥 Healthcare
The Trump administration reversed its policy allowing federal funds for purchasing and distributing fentanyl detection strips used to test street drugs for contaminants. The Substance Abuse and Mental Health Services Administration issued guidance ending the practice as part of the administration's opposition to harm reduction initiatives. This change eliminates access to potentially life-saving drug testing resources for vulnerable populations.
Active
TERM 2
January 23 2025 · 586 days ago
🏥 Healthcare
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana to a less-dangerous drug category under federal law. The change impacts federal regulation of marijuana in dozens of states that permit medical use, though it does not fully legalize marijuana federally. This significantly alters how the drug is regulated and enforced at the federal level.
Pending
TERM 2
January 23 2025 · 586 days ago
🏥 Healthcare
President Trump selected Erica Schwartz, former deputy surgeon general and medical doctor, to lead the Centers for Disease Control and Prevention. Schwartz, a retired rear admiral in the U.S. Public Health Service Commissioned Corps, requires Senate confirmation. The CDC has been without permanent leadership for eight months.
Active
TERM 2
January 2025 · 587 days ago
🏥 Healthcare
The Federal Trade Commission and four states filed suit against the World Professional Association for Transgender Health, alleging deceptive claims about gender-affirming care for minors. The action targets medical professionals and organizations providing transgender healthcare services. This represents a coordinated federal and state effort to restrict access to gender-affirming medical care for transgender youth.
Active
TERM 2
January 2025 · 588 days ago
🏥 Healthcare
The Trump administration froze millions of dollars in federal funding for New York's Medicaid Fraud Control Unit (MFCU), which investigates and prosecutes healthcare provider fraud and patient abuse in Medicaid facilities. The action eliminates dedicated enforcement capacity for detecting fraud and protecting vulnerable patients in state Medicaid programs. New York loses federal resources for healthcare oversight and fraud prevention affecting thousands of Medicaid beneficiaries.
Active
TERM 2
January 21 2025 · 588 days ago
🏥 Healthcare
The FDA appointed Katherine Szarama as acting director of the Center for Biologics Evaluation and Research, replacing Vinay Prasad. This unit regulates vaccines and biological products for human use. The leadership change may impact vaccine approval processes and biological product oversight.